Advertisement
Loading...

BioNTech SE

BNTX•NASDAQ
Healthcare
Biotechnology
$89.70
$-2.53(-2.74%)
U.S. Market is Open • 10:26

BioNTech SE (BNTX) Stock Overview

Explore BioNTech SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap23.3B
P/E Ratio-15.83
EPS (TTM)$-5.97
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$73.64
3 Months$99.79
1 Year Target$76.95

BNTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioNTech SE (BNTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.13, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $76.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.83 and a market capitalization of 23.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.26%
5-Day Change
-1.49%
1-Month Change
-6.52%
3-Month Change
-13.11%
6-Month Change
-10.77%
Year-to-Date (YTD) Change
-3.37%
1-Year Change
-0.11%
3-Year Change
-14.75%
5-Year Change
-52.28%
All-Time (Max) Change
546.00%

Contact Information

https://www.biontech.de
49 6131 9084 0
An der Goldgrube 12, Mainz, NaN, 55131

Company Facts

6,772 Employees
IPO DateOct 10, 2019
CountryDE
Actively Trading

Frequently Asked Questions